At the end of this session, learners can define healthy aging, describe different health promotional strategies, and differentiate between activities most meaningful for those independently living vs institutional living.
At the end of this session, learners can compare care processes and outcomes of nursing home vs assisted living, compare caregiver burden between nursing home and assisted living, and explain cost structures.
At the end of this session, learners can understand how autonomy may be restricted in institutional living, predict situations in which aging in place is most appropriate, and plan for conversations about transition to institutional living.
At the end of this session, learners can understand the benefits of person-centered care in long term care, compare different management approaches and critique a person-centered plan to improve the quality of live.
Don’t miss this grand rounds webinar on HRS-AKI—a high-stakes diagnosis in advanced liver disease. Learn key clinical pearls, real-world cases, and the latest evidence to guide treatment decisions. Ideal for the full interprofessional care team.
Join leading experts for this unique live webinar, designed as a mock Pharmacy and Therapeutics (P&T) Committee meeting to involve managed care decision-makers in an interactive learning experience that can be applied in the real-world setting.
Contact Hours Available: Welcome to the Texas Suicide Prevention Symposium 2025, a fully virtual event dedicated to advancing suicide prevention efforts across Texas and beyond.
Join us for this live symposium offered in conjunction with the World Transplant Congress 2025, featuring two renowned kidney transplant experts.
Join us for a dynamic multidisciplinary discussion featuring an expert breast oncologist and pathologist who will share real-world challenges in HER2 testing and interpretation identified through a new nationwide survey of pathologists.
Wendy Wright, from FHEA, will speak both days on a variety of topics important to NPs of all specialties. More information to follow. Please check back in with us.
